EXPLORING THE SYNERGY: CHINESE FEMALE TENNIS PLAYERS AND CHANSU-MEDICATED SERUM'S POTENTIAL IN INHIBITING BREAST CANCER CELL PROLIFERATION THROUGH APOPTOSIS AND G2 ARREST

Authors

  • Xinxin Zhang Department of Oncology Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233003, China
  • Yihao Wang Department of Oncology Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233003, China
  • Kaiji Gao Department of Oncology Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233003, China
  • Jianguang Jia Department of Oncology Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233003, China

Keywords:

breast cancer; side population; Chansu-medicated serum; apoptosis; G2 arrest; Chinese players, Tennis

Abstract

This study delves into the synergy between Chinese female tennis players and the potential of Chansu-Medicated Serum in inhibiting breast cancer cell proliferation through apoptosis and G2 arrest. Chinese female tennis players have garnered international recognition for their achievements on the court and their philanthropic endeavors off it. This research investigates the intersection of their impact and the advancement of breast cancer research. Chansu-Medicated Serum, a traditional Chinese medicine derivative, presents promising mechanisms for inhibiting breast cancer cell proliferation, including apoptosis induction and G2 cell cycle arrest. By exploring this conjunction, we aim to shed light on the possible contributions of these athletes and traditional medicine to the ongoing battle against breast cancer.

Downloads

Published

2023-10-20